The Company’s mission is to develop effective T-regulatory cell (TREG) based therapies for autoimmune diseases to improve the quality of life of patients and their families.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for PolTREG on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.